Improving Clinical Decision Making with Engaging CME, Tools, & Resources
EMPOWER - Ocular Surface Disease: Latest Innovations In Dry Eye And Meibomian Gland Dysfunction
Jacob Lang
Josh Davidson, OD, FSLS, FAAO
Mark Dunbar
Improving Early Detection of Geographic Atrophy
Alexandria May, PharmD, BCPS
Hasenin Al-khersan, MD
Extended Dosing Strategies for Diabetic Retinopathy and DME
Michael A. Klufas, MD
What's Next in Uveitis Care?
Steven Yeh, MD, FASRS
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Applying CAS, EUGOGO, VISA: A Micro Case
Why QoL Measures Change TED Management
Kimberly Cockerham, MD
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD
Janis T. Eells, Ph.D.
David Boyer, MD
Eleonora Lad, MD, PhD
Marion R. Munk, MD, PhD
ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Seeing the Future of Vitreoretinal Care
Prethy Rao MD, MPH, FACS
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Overcoming Real-World Barriers to TED Treatment
Recognizing Geographic Atrophy Progression in AMD
Brian P. McDonough, MD, FAAFP
Jaclyn Kovach, MD
Advancing Uveitis Care: Emerging Challenges and Research Opportunities
Observation vs. Vitrectomy for Floaters
Kyle Davis Kovacs, MD
Matthew Starr, MD
Nita Valikodath, MD, MS
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.